MatsukiyoCocokara & Co.: history, ownership, mission, how it works & makes money

Born from the October 1, 2021 merger of Matsumotokiyoshi Holdings and Cocokara Fine, MatsukiyoCocokara & Co. has quickly consolidated its place in Japan's health and beauty landscape, tracing roots back to 1932 and today operating 3,499 stores nationwide (including 1,002 pharmacies and 120 Health Support Pharmacies as of March 31, 2025); the publicly traded 3088.T group reported net sales of 1,061.6 billion yen for the fiscal year ending March 31, 2025 (a 3.8% increase year-on-year), opened 24 new dispensing pharmacy stores in Q1 FY2025, and maintains a market capitalization of about 1.14 trillion yen (Dec 12, 2025), supported by a diversified model-retail, wholesale and management support-410,275,830 shares issued, a workforce of 12,753 employees (down 4.62% from the prior year) and recognition as a Health and Productivity Management White 500 organization, all of which frame the company's mission to integrate physical stores, digital services and private brands to reshape everyday health and beauty access across Japan.

MatsukiyoCocokara & Co. (3088.T): Intro

• Established: October 1, 2021 (merger)
• Heritage: Origins back to 1932 (Matsumotokiyoshi)
• Ticker: 3088.T (Tokyo Stock Exchange)

• Pre-merger growth: Matsumotokiyoshi built a national drugstore footprint; Cocokara Fine developed pharmacy and health-service capabilities.
• Merger rationale (2021): Combine scale in retail purchasing, unify loyalty and private-label strategies, expand pharmacy services and omnichannel reach.
• Post-merger expansion: Continued store openings and integration of dispensing pharmacy network to capture aging-population demand and prescription volumes.

• Publicly listed company (3088.T) grouping former Matsumotokiyoshi and Cocokara Fine operations under a single corporate holding structure.
• Governance: Integrated board and executive teams drawn from both legacy companies to manage retail, pharmacy, distribution and private-label businesses.

• Mission: Provide accessible everyday health and beauty products, strengthen pharmacy services and support community health.
• Positioning: Largest integrated drugstore + pharmacy operator in Japan by combined store count and product breadth.
• Key priorities: Expand dispensing pharmacies, increase Health Support Pharmacy certification, digital loyalty and private-label growth, and workplace health initiatives (recognized by White 500).

• Retail stores: Drugstore format selling OTC medicines, cosmetics, daily goods, supplements and household items across 3,499 locations.
• Pharmacy services: Dispensing prescriptions through 1,002 pharmacies, expanding community healthcare roles and Health Support Pharmacy designations (120 stores).
• Omnichannel: In-store sales complemented by online ordering, delivery and click-and-collect solutions tied to loyalty programs.
• Distribution & procurement: Centralized purchasing and distribution to leverage scale and private-label product development.

• In-store merchandise sales: OTC drugs, cosmetics, daily necessities and food-primary revenue driver.
• Prescription dispensing: Pharmacy revenues from prescription fulfillment and related health services.
• Private-label products: Higher-margin owned brands across health, beauty and household categories.
• Services and value-added care: Health consultations, vaccination/health check collaborations, and pharmacy-based services.
• Omnichannel and logistics: Fees and margins from online order fulfillment, home delivery and membership-based services.

• FY 2025 net sales: ¥1,061.6 billion (+3.8% YoY).
• Store network: 3,499 total stores; 1,002 pharmacies; 120 Health Support Pharmacies (as of March 31, 2025).
• Q1 FY2025 openings: 24 new dispensing pharmacies (19 Matsumotokiyoshi Group, 5 Cocokara Fine Group).
• Corporate recognition: Selected as Health and Productivity Management Outstanding Organization 2025 (White 500).

MatsukiyoCocokara & Co. (3088.T): History

• Public listing: Tokyo Stock Exchange, ticker 3088
• Market capitalization: ≈1.14 trillion yen (as of December 12, 2025)
• Shares issued: 410,275,830 (as of March 31, 2025)
• Fiscal year end: March 31

• Retail sales from a network of drugstores and cosmetics outlets selling pharmaceuticals, OTC products, cosmetics, household goods and food items.
• Pharmacy services and prescription fulfillment, generating recurring revenue and customer loyalty.
• Private-label products and merchandising strategies that improve margins.
• Membership and loyalty programs that increase basket size and repeat visits.
• Operational efficiency initiatives-reflected in a reduced workforce (-4.62% YoY)-to lower costs and sustain profitability.

• Deliver accessible everyday healthcare and wellness products to local communities.
• Enhance customer health outcomes through integrated pharmacy and consultation services.
• Pursue sustainable growth via store optimization, private-label expansion and digital customer engagement.

MatsukiyoCocokara & Co. (3088.T): Ownership Structure

• Established operational integration: over 3,400 domestic stores (as of October 2021).
• Ticker: 3088.T (listed on the Tokyo Stock Exchange).
• Strategic focus: private brand development, omnichannel integration (stores + apps + e‑commerce), and regional comprehensive care systems.

• Mission and values emphasize accessibility, enjoyment, and professional community-based care-aiming to lead Japan's health & beauty market.
• Private brand strategy: expand margin-accretive owned labels (e.g., KNOWLEDGE, FEMRISA) to meet diverse customer needs and capture higher lifetime value.
• Omnichannel model: integrate >3,400 physical touchpoints with apps and e-commerce; digital offerings like MatsukiyoCocokara Me streamline pharmacy services and patient/customer interactions.
• Community care: develop regional comprehensive care systems-providing expert-led in-store clinics, pharmacy services, and local health programs.

MatsukiyoCocokara & Co. (3088.T): Mission and Values

• Integrated retail + pharmacy model: co-locating drugstore retail with insurance-dispensing pharmacy services for one-stop health access.
• Wholesale & franchise support: centralized procurement, inventory and distribution for group and partner retailers.
• Management support: back-office, private-brand R&D, store rollout and asset operation to capture economies of scale.

• Retail sales margin: product markup on OTC drugs, cosmetics, daily necessities and food items sold through company-operated stores and franchises.
• Pharmacy dispensing fees: revenue from insurance-dispensed prescriptions and associated consultation services; supplemented by private-pay health services where applicable.
• Wholesale margins: procurement and distribution margins from selling product assortments to franchisees and partner retailers.
• Private-brand contribution: higher-margin private-label goods developed and marketed through the group's retail network.
• Management and service fees: income from management support contracts, store construction/maintenance, asset management, and insurance-agency commissions.

• Enhance community healthcare through expanded pharmacy services and pharmacist dispatch programs.
• Scale private-brand offerings to lift margins and customer loyalty.
• Optimize supply-chain efficiencies via wholesale and distribution scale to support both company stores and franchisees.
• Leverage management support services to standardize operations, reduce costs, and accelerate store openings.

MatsukiyoCocokara & Co. (3088.T): How It Works

• Founded through the integration of two leading Japanese drugstore chains to create a nationwide health‑and‑beauty retail platform focused on customer health, convenience and lifestyle support.
• Mission: to deliver everyday health and beauty solutions, promote preventive health management, and build a resilient omnichannel supply chain that connects manufacturers, franchisees and consumers across Japan.
• Recognition: selected as a 'Health and Productivity Management Outstanding Organization 2025 (Large Enterprise Category - White 500)' by the Ministry of Economy, Trade and Industry and the Japan Health Council, reflecting emphasis on internal health management practices.

• Listed on the Tokyo Stock Exchange under ticker 3088.T; ownership is a mix of institutional investors, domestic retail investors and strategic corporate shareholders.
• Organized into core business segments-Retail, Wholesale, and Management Support-plus group companies and franchise networks that extend reach and product assortment.

• Retail network: operates company-owned stores and supports franchisees to sell pharmaceuticals, OTC medication, cosmetics, daily consumables, nutritional supplements and related services.
• Wholesale operations: procures products from suppliers, distributes to group companies and external partners, develops franchise supply programs and manages inventory flows to maintain product availability.
• Management support & services: provides centralized functions for group companies and franchisees including IT, procurement, store construction and maintenance, private‑brand (PB) product planning, asset management, and insurance agency operations (non‑life and life insurance).
• Omnichannel sales: combines in‑store merchandising with digital channels (e‑commerce, click‑and‑collect, loyalty programs) to capture demand across age cohorts and regions.

• Retail sales: primary revenue driver-direct sale of health & beauty products, prescriptions and OTC pharmaceuticals, cosmetics, daily goods and services in physical stores and online.
• Wholesale margins: revenue from buying and reselling products to group companies, franchisees and external retailers; contributes stable flows through bulk procurement and distribution contracts.
• Management support fees and services: income from franchising, store construction/maintenance contracts, private brand development, administrative outsourcing, insurance agency commissions and asset leasing/management.

• Scale purchasing and private‑brand development reduce COGS and increase gross margins.
• Franchise and wholesale networks expand reach with lower capital intensity versus company‑owned stores.
• Cross‑selling (pharmacy + cosmetics + insurance services) increases basket size per customer.
• Operational synergies from centralized logistics, procurement and IT lower SG&A per store as the chain scales.

• Expansion and optimization of store footprint, balancing flagship urban stores with community pharmacies.
• Development of private brands to capture higher-margin sales and differentiate assortment.
• Investment in digital channels and loyalty programs to increase customer frequency and lifetime value.
• Provision of management and back‑office services to franchisees to accelerate network growth and maintain quality standards.

MatsukiyoCocokara & Co. (3088.T): How It Makes Money

• Retail stores: over 3,400 domestic stores as of October 2021, spanning drugstores, cosmetics, daily-goods and pharmacy counters.
• Private-label and brand products: higher-margin in-house brands and exclusive supplier arrangements boost gross margin.
• Pharmacy/medical services: prescription dispensing and health-related services increase basket size and frequency.
• E-commerce & loyalty: online sales and loyalty-program-driven promotions improve retention and capture multichannel demand.
• Wholesale & distribution: supplying partners and smaller retailers complements retail operations and optimizes logistics.

• Scale and density: high store count in urban and suburban catchments increases share-of-wallet for everyday health & beauty purchases.
• Category mix optimization: balancing fast-moving OTC, cosmetics, daily consumables and higher-margin private-label goods.
• Cost and logistics efficiency: centralized purchasing, distribution centers and inventory turn strategies reduce working capital needs.
• Cross-channel promotions: loyalty data and integrated promotions drive higher lifetime value per customer.